In a regulatory filing, Expensify (EXFY) announced a leadership transition, following the resignation of COO and board member Anu Muralidharan.
Effective December 29, 2025, Muralidharan stepped down from all executive and board positions. Daniel Vidal, the company’s current Chief Strategy Officer and Director, has assumed
Follow us on Google for the latest stock news
MP Materials (NYSE: MP) and USA Rare Earth (NASDAQ: USAR) are both after the same goal: to build a supply...
Total federal debt is nearing an ominous milestone in a few years, but a potentially more troubling tipping point could...
Valentine’s Day dinner at White Castle with candles, attentive wait staff and white tablecloths was a treasured experience for Krystal...
On February 13, 2026, Affinity Asset Advisors disclosed a purchase of 61,500 shares of Apogee Therapeutics (NASDAQ:APGE), an estimated $3.87...
Sunaina Sinha Haldea is the global head of Private Capital Advisory at Raymond James. She founded Cebile Capital and scaled...
Healthcare industry stocks are traditionally good hedges against technology and other growth stocks, because they tend to perform well when...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.
